12:00 AM
 | 
Feb 06, 2012
 |  BC Week In Review  |  Company News  |  Deals

Orexo, J&J deal

Orexo and Johnson & Johnson's Janssen Pharmaceuticals Inc. (formerly Ortho-McNeil-Janssen Pharmaceuticals Inc.) and Janssen Pharmaceutica N.V. subsidiaries, mutually terminated a 2010 deal granting the subsidiaries exclusive, worldwide rights to develop and commercialize Orexo's OX-CLI...

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >